★
Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

Guided View
New to markets (prices, yields, YTD, market cap)? We explain every term as you browse, in plain English. Same data, with the help built in.

Expert View
You already know the market. Just the data: clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Security record · archived quarter

ZURA

Zura Bio Limited · Healthcare · Biotechnology

4.00 0.0% mkt cap $379.99M quote delayed (FMP) · as of Oct 12 22:08 UTC — separate from filing data below

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
8Tracked holders
+2Δ holders
3.98MShares held
$16.15MReported value
+2New positions
−0Exits
Strongly Rising Conviction score 67/100 How these are computed → Explain this at the Research Desk →

Momentum inputs (comparable managers): holder breadth +30.0% · share flow +6.6% · net new positions +20.0% — formula
Broad accumulation — rising shares across more holders

All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024

Ownership over time
QuarterHoldersΔSharesReported valueNewExits
Q2 2026 44 +6 19.12M $111.66M +15 −9
Q1 2026 39 +4 16.55M $97.28M +6 −2
Q4 2025 35 -1 16.01M $83.89M — −1
Q3 2025 16 +3 16.65M $72.09M +3 —
Q2 2025 10 -1 5.96M $6.26M — −1
Q1 2025 8 -1 4.76M $6.14M +1 −2
Q4 2024 9 0 5.19M $12.99M +1 −1
Q3 2024 8 +2 3.98M $16.15M +2 —
Q2 2024 6 — 3.73M $12.85M — —
Holder count
Who holds it · Q3 2024
#ManagerSharesΔ sharesValueTheir weightHeld
1 Point72 Asset Management ✦ 2.41M 0.0% $9.80M 0.0% Held 2 SEC ↗
2 Geode Capital Management ✦ (passive) 912.62K +70.6% $3.71M 0.0% ▲ Add 2 SEC ↗ ×2
3 Citadel Advisors ✦ 336.83K -46.8% $1.37M 0.0% ▼ Trim 2 SEC ↗
4 Two Sigma Investments ✦ 176.97K +50.3% $718,510 0.0% ▲ Add 2 SEC ↗
5 Renaissance Technologies ✦ 63.90K +267.2% $259,434 0.0% ▲ Add 2 SEC ↗
6 Millennium Management ✦ 43.86K New $178,063 0.0% New 1 SEC ↗
7 T. Rowe Price ✦ 15.32K New $63,000 0.0% New 1 SEC ↗
8 AQR Capital Management ✦ 14.50K +17.7% $58,878 0.0% ▲ Add 2 SEC ↗ ×3

“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.

New buyers

Millennium Management $178,063 0.0%
T. Rowe Price $63,000 0.0%

Exited

No tracked exits this quarter.

Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 92 holders, 61.32M shares, $364.31M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.

Frequently co-owned

What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.

Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR. Reporting period: Q3 2024 · Methodology · Get this via the API